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Introduction
The most frequent cause of bacterial meningitis in many 
countries is Streptococcus pneumoniae [1], which is es-
timated to be responsible for about 10% of all deaths of 
children aged 1-59 months worldwide [2]. In Italy, the 
average annual incidence of meningitis due to S. pneu-
moniae is 4/100,000 inhabitants among children aged 
less than one year, and 1-1.5/100,000 inhabitants among 
those aged 1-4 years [3]. 
Despite the availability of effective antibacterial agents 
and vaccines, pneumococcal meningitis and sepsis are 
still associated with high mortality rates [4, 5] and seri-
ous sequelae, including 30% of the cases of neurological 
handicap (i.e. spasticity, paresis or epileptic disorders), 
19% of the cases of mental retardation, and frequent loss 
of hearing [6].
The heptavalent pneumococcal conjugate vaccine 
(PCV7) has played a major role in reducing the incidence 
of diseases related to pneumococcal infection [7, 8]. It is 
estimated that it is 91% efficacious in preventing inva-
sive pneumococcal diseases due to the strains covered 
by the vaccine [2], and it has also been found to protect 
unvaccinated children and adults as a result of herd im-
munity [9]. However, there has recently been an increase 
in the incidence of pneumococcal meningitis related to 
serotypes not contained in PCV7 [10]. 
We describe the case of a 17-month-old child vaccinated 
with PCV7 who developed bacterial meningitis compli-
cated by subdural empyema and deafness caused by S. 
pneumoniae serotype 7F. The 7F strain is not contained 
in PCV7 (the only vaccine on the market at the time of 
the onset of meningitis) but is included in the new pedi-
atric 13-valent PCV, which may therefore prevent cases 
such as this in the future.
Case report
The 17-month-old boy was born by means of eutocic de-
livery, and experienced a physiological neonatal period 
and normal psychomotor development. He was vacci-
nated with three doses of hexavalent vaccine, PCV7 and 
meningococcal C vaccine after three, five and 12 months 
of life. His remote pathological anamnesis was not char-
acterised by any disease of note.
The child was brought to our Emergency Department 
because of the appearance of a convulsive crisis in hy-
perpyrexia (maximum rectal temperature 39.5°C) asso-
ciated with vomiting. Upon admission, mild rigor was 
observed with a positive Brudzinski sign in the absence 
of any other focal signs of infection. A lumbar punc-
ture was performed and revealed the presence of turbid 
liquor, hyperproteinorrhachia and hypoglycorrhachia 
(white blood cell [WBC] count 1,460/mm3; proteins, 
234 mg/dL; glucose 1 mg/dL), with evidence of solu-
ble S. pneumoniae antigen positivity. Blood chemistry 
tests revealed an increase in the indices of inflammation 
(WBCs 7,660/mm3; neutrophils 75.1%; C-reactive pro-
tein 268 mg/L). An electroencephalogram showed the 
presence of diffuse slow anomalies in the absence of fo-
cal or paroxysmal anomalies. 
Intravenous antibacterial therapy with ceftriaxone 
(100 mg/kg/day) and vancomycin (40 mg/kg/day) was 
started. Vancomycin was discontinued after three days 
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because the cerebrospinal fluid (CSF) and blood cultures 
were positive for ceftriaxone-sensitive S. pneumoniae. 
Polymerase chain reaction (PCR) typing of the bacterial 
strain subsequently identified an infection due to sero-
type 7F.
The child initially showed a fair clinical response, 
with an improvement in blood chemistry parameters 
(WBCs 5,840/mm3; neutrophils 65.4%; C-reactive pro-
tein, 110 mg/L) and an improvement in the CSF obtained 
72 hours after the beginning of therapy (WBCs 100/
mm3; proteins 178 mg/dL; glucose 39 mg/dL; negative 
CSF culture). However, although there were some signs 
of a response to the chosen treatment, he continued pre-
senting daily peaks of fever, and a physical examina-
tion revealed the persistence of slight rigor nuchalis and 
difficulty in maintaining a seated or erect posture. For 
this reason, despite the improvement in blood chemistry 
values (WBCs 4,970/mm3; neutrophils 52.3%; C-reac-
tive protein 33 mg/L), a further lumbar puncture was 
performed about ten days after admission that revealed 
clear CSF with WBCs 60/mm3, proteins 78 mg/dL and 
glucose 43 mg/dL; the CSF culture was negative, as was 
a PCR search for S. pneumoniae. 
Brain and spinal magnetic resonance (MR) imaging with 
contrast revealed the presence of a pool of purulent fluid 
along the right hemisphere without any apparent mass 
effect and the absence of parenchymal injuries (Fig. 
1A). Consequently, ceftriaxone was discontinued, and 
double intravenous antibacterial therapy with meropen-
em (100 mg/kg/day) and vancomycin (40 mg/kg/day) 
was started. A control electroencephalogram showed the 
presence of a substantial amount of polymorphic, slow 
and intermittent theta-delta activity with a medium-large 
amplitude on the left occipital sector, particularly during 
sleep and awakening.
After about 10 days of the new treatment, hyperpyrexia 
persisted and was associated with occasional episodes 
of vomiting. The neurological picture was stationary, 
and there was a new increase in the inflammation indi-
ces (WBCs 12,890/mm3; neutrophils 82.3%; C-reactive 
protein 173 mg/L). It was therefore decided to repeat the 
brain and spinal MR imaging, which revealed a worsen-
ing in the radiological picture with an increase in the 
narrow, extra-cerebral, right hemisphere parieto-occip-
ital pool (Fig. 1B). Brain computed tomography (CT) 
confirmed the presence of a narrow (maximum width 
3 mm), hypodense extracerebral pool with a right pari-
eto-occipital subdural localisation that was compressing 
the underlying parenchyma. 
For this reason, the child underwent emergency neuro-
surgery and the fluid was removed by means of burr hole 
drainage. The subsequent control brain CT scan was 
negative for intracranial hemorrhaging and alterations in 
the encephalic parenchyma. 
The post-operative course was characterided by the im-
mediate complete remission of fever, and the normalisa-
tion of the inflammation indices. Antibiotic therapy with 
meropenem and vancomycin was continued for seven 
days. There was a significant neurological improvement, 
and the child recovered his ability to walk. However, 
brainstem auditory evoked responses (BAERs) and au-
diometry revealed profound sensory hypoacusia and the 
child received a cochlear implant. One year later, he is 
attending speech therapy and psychomotricity sessions 
with good results. No underlying immunological disor-
der was detected to explain this complication.
Fig. 1A. mr image showing a pool of purulent fluid along the 
right hemisphere without any apparent mass effect, and the ab-
sence of parenchymal injuries.
Fig. 1B. mr image showing the worsened radiological picture, 
with an increase in the narrow, extra-cerebral, right hemisphere 
parieto-occipital pool of fluid.
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Discussion
Subdural empyema is a serious complication of pediatric 
bacterial meningitis, accounts for 15-20% of all local-
ised intracranial infections, and represents a neurosurgi-
cal emergency. Its appearance is rarer in children than 
adults [11] but, as in our case, it seems to be more fre-
quently associated with persistent fever during adequate 
antibacterial therapy and no neurological improvement. 
In the case of bacterial meningitis, the persistence of 
fever with pathological neurological symptoms should 
therefore arouse a suspicion of subdural empyema and 
all of the emergency diagnostic procedures should be 
carried out because an early diagnosis infact makes it 
possible to undertake appropriate neurosurgery with the 
aim of improving the prognosis.
To diagnose subdural empyema in the presence of any 
clinical suspicion, brain CT is generally used because it 
is usually the most rapidly available neuroimaging tech-
nique, although MR is more sensitive in revealing anom-
alies of the cerebral parenchyma. Once the diagnosis has 
been made, it is equally important to drain the empyema 
as soon as possible in order to improve the prognosis 
of the patient. This may be done by means of burr hole 
drainage (as in our case) or craniotomy, but recent stud-
ies have shown that the former is the least invasive and 
most effective neurosurgical procedure, and particularly 
suitable for infants and young children [12].
Our case also showed that pneumococcal meningitis can 
be associated with deafness. Hearing loss is still a major 
cause of disability among the survivors of meningitis due 
to S. pneumoniae, even in the case of adequate antibiotic 
therapy [13]. S. pneumoniae can cause cochlear ossifica-
tion, which can subsequently hinder surgical correction 
and prevent a favourable outcome. It is therefore essen-
tial to correct the defect promptly: the rapid placement 
of a cochlear implant can reduce the risk of ossification 
and favour surgical success [13, 14].
The introduction of PCV7 has reduced the incidence of 
pneumococcal meningitis, but there are still many pneu-
mococcal serotypes that are not covered by the vaccine. 
The use of PCV13 can further reduce the incidence of 
invasive pneumococcal disease, but it is still necessary 
to continue active surveillance of the circulating pneu-
mococcal serotypes using new and highly sensitive diag-
nostic methods such as PCR. The collection of complete 
epidemiological data will provide the basis for the devel-
opment of vaccines that can provide broader protection 
and therefore further reduce the mortality and sequelae 
due to pneumococcal meningitis.
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